[Form 4] Axon Enterprise, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Hadi Partovi, a director of Axon Enterprise, Inc. (AXON), reported a non-derivative transaction on 08/29/2025 reflecting a grant of 100 restricted stock units (RSUs) under the Axon Second Amended and Restated 2022 Stock Incentive Plan that vested in full on the grant date. The filing shows the RSUs were issued at a $0 price and that Mr. Partovi beneficially owned 238,038 shares following the transaction. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Partovi on 09/03/2025. The filing indicates the reporter is a director and the form was filed by one reporting person.

Positive

• Director identified as reporting person, clarifying relationship to issuer
• 100 RSUs granted and vested in full on grant date, explicitly stated in explanation
• Post-transaction beneficial ownership disclosed: 238,038 shares, providing clear ownership context
• Form filed by one reporting person, with signature by attorney-in-fact documented

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director compensation grant fully vested on grant date; disclosure is standard for Section 16 reporting.

The Form 4 documents a director-level equity award under the company's 2022 Stock Incentive Plan with full vesting on grant date. The report is factual and complies with Section 16 disclosure by identifying the reporter, relationship to the issuer (Director), transaction date, amount, and resulting beneficial ownership. There is no additional information about vesting conditions, plan terms beyond the plan name, or transfers, so material governance issues are not evident from this filing alone.

Securities Analyst

TL;DR: A small, routine equity grant was reported; ownership totals are disclosed precisely.

The filing shows a grant of 100 RSUs that vested immediately and a post-transaction beneficial ownership of 238,038 shares. The transaction was recorded at a $0 price consistent with an equity grant rather than an open-market purchase or sale. The disclosure provides necessary transactional detail for investor records but does not include market-moving financial metrics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Partovi Hadi

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		A		100(1)	A	$0	238,038	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units pursuant to the Axon Enterprise, Inc. Second Amended and Restated 2022 Stock Incentive Plan. The shares vested in full on the grant date.

Remarks:

	/s/ Hadi Partovi, by Isaiah Fields, Attorney-in-Fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Hadi Partovi report on the AXON Form 4?

The Form 4 reports a grant of 100 restricted stock units (RSUs) dated 08/29/2025 that vested in full on the grant date.

How many AXON shares did Hadi Partovi beneficially own after the reported transaction?

The filing shows 238,038 shares beneficially owned following the reported transaction.

What price was reported for the transaction on the AXON Form 4?

The transaction is reported at a $0 price, consistent with a stock grant rather than a purchase.

What is Hadi Partovi's relationship to Axon Enterprise, Inc. according to the filing?

The Form 4 lists Hadi Partovi as a Director of Axon Enterprise, Inc.

When was the Form 4 signed and who signed it?

The signature block shows the form signed 09/03/2025 as /s/ Hadi Partovi, by Isaiah Fields, Attorney-in-Fact.